
Actemra Market, By Indication (Rheumatoid Arthritis, Giant Cell Arteritis (GCA), Polyarticular Juvenile Idiopathic Arthritis (PJIA), Systemic Juvenile Idiopathic Arthritis (SJIA), Cytokine Release Syndrome (CRS), and Systemic Sclerosis-associated Intersti
Description
The Global Actemra Market is estimated to be valued at USD 3,023.6 Mn in 2025 and is expected to reach USD 2,373.6 Mn by 2032, declining at a compound annual growth rate (CAGR) of -3.4% from 2025 to 2032.
The global Actemra market has faced a slowdown in recent years, marked by a negative compound annual growth rate (CAGR). While the treatment remains effective in managing autoimmune disorders like rheumatoid arthritis and giant cell arteritis, several challenges have hindered market growth. High treatment costs, potential side effects, and the availability of alternative therapies have limited the demand for Actemra. The entry of biosimilars and the expiration of patents further intensified competition, slowing the market's expansion. These factors combined have contributed to a decline in market growth, resulting in limited prospects for significant expansion in the near term.
Market Dynamics
The market still presents some opportunities for recovery, primarily through the growing focus on personalized medicine and expanding research that could uncover new therapeutic indications for Actemra. Emerging markets remain a potential growth area, but the overall market trajectory is likely to remain subdued, with limited prospects for significant expansion due to pricing pressures and the increasing presence of biosimilars.
Key Features of the Study
The global Actemra market has faced a slowdown in recent years, marked by a negative compound annual growth rate (CAGR). While the treatment remains effective in managing autoimmune disorders like rheumatoid arthritis and giant cell arteritis, several challenges have hindered market growth. High treatment costs, potential side effects, and the availability of alternative therapies have limited the demand for Actemra. The entry of biosimilars and the expiration of patents further intensified competition, slowing the market's expansion. These factors combined have contributed to a decline in market growth, resulting in limited prospects for significant expansion in the near term.
Market Dynamics
The market still presents some opportunities for recovery, primarily through the growing focus on personalized medicine and expanding research that could uncover new therapeutic indications for Actemra. Emerging markets remain a potential growth area, but the overall market trajectory is likely to remain subdued, with limited prospects for significant expansion due to pricing pressures and the increasing presence of biosimilars.
Key Features of the Study
- This report provides in-depth analysis of the global Actemra market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Actemra market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Genentech (Part of Roche)and Chugai Pharmaceutical Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global Actemra market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Actemra market
- Indication Insights (Revenue, USD Mn, 2020 - 2032)
- Rheumatoid Arthritis
- Giant Cell Arteritis (GCA)
- Polyarticular Juvenile Idiopathic Arthritis (PJIA)
- Systemic Juvenile Idiopathic Arthritis (SJIA)
- Cytokine Release Syndrome (CRS)
- Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
- Strength Insights (Revenue, USD Mn, 2020 - 2032)
- 80 mg/4 mL (20 mg/mL)
- 200 mg/10 mL (20 mg/mL)
- 400 mg/20 mL (20 mg/mL)
- 162 mg/0.9 mL for Injection
- Packaging Insights (Revenue, USD Mn, 2020 - 2032)
- Single-dose vials
- Single-dose prefilled syringe or autoinjector
- Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
- Subcutaneous
- Intravenous
- Age Group Insights (Revenue, USD Mn, 2020 - 2032)
- Adult
- Pediatric
- Geriatric
- Sales Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Online
- Offline
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals
- Specialized Infusion Centers
- Others (Academics and Research Institutes, etc.)
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Genentech (Part of Roche)
- Chugai Pharmaceutical Co., Ltd.
Table of Contents
165 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Actemra Market, By Indication
- Global Actemra Market, By Strength
- Global Actemra Market, By Packaging
- Global Actemra Market, By Route of Administration
- Global Actemra Market, By Age Group
- Global Actemra Market, By Sales Channel
- Global Actemra Market, By End User
- Global Actemra Market, By Region
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
- Reimbursement Scenario
- Epidemiology
- Pricing Analysis
- 4. Global Actemra Market, By Indication, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Rheumatoid Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Giant Cell Arteritis (GCA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Polyarticular Juvenile Idiopathic Arthritis (PJIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Systemic Juvenile Idiopathic Arthritis (SJIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cytokine Release Syndrome (CRS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 5. Global Actemra Market, By Strength, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- 80 mg/4 mL (20 mg/mL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 200 mg/10 mL (20 mg/mL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 400 mg/20 mL (20 mg/mL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 162 mg/0.9 mL for Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 6. Global Actemra Market, By Packaging, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Single-dose vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Single-dose prefilled syringe or autoinjector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 7. Global Actemra Market, By Route of Administration, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 8. Global Actemra Market, By Age Group, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 9. Global Actemra Market, By Sales Channel, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 10. Global Actemra Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Specialized Infusion Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others (Academics and Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 11. Global Actemra Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Packaging, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
- 12. Competitive Landscape
- Genentech (Part of Roche)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Chugai Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- 14. References and Research Methodology
- References
- Research Methodology
- About us
- *Browse 32 market data tables and 28 figures on ‘Actemra Market' - Global forecast to 2032
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.